Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


11.03.2019

4 Acta Neuropathol
1 BMC Cancer
1 Br J Neurosurg
1 Clin Cancer Res
2 Int J Radiat Oncol Biol Phys
12 J Neurooncol
1 J Neuropathol Exp Neurol
2 J Neurosurg
1 Neuro Oncol
3 Neurology
3 Neurosurgery
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. ELLISON DW, Hawkins C, Jones DTW, Onar-Thomas A, et al
    cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation.
    Acta Neuropathol. 2019 Mar 8. pii: 10.1007/s00401-019-01987.
    PubMed     Text format    

  2. BLANLUET M, Masliah-Planchon J, Giurgea I, Bielle F, et al
    SHH medulloblastoma in a young adult with a TCF4 germline pathogenic variation.
    Acta Neuropathol. 2019 Mar 8. pii: 10.1007/s00401-019-01983.
    PubMed     Text format    

  3. HELLWIG M, Lauffer MC, Bockmayr M, Spohn M, et al
    TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
    Acta Neuropathol. 2019 Mar 4. pii: 10.1007/s00401-019-01982.
    PubMed     Text format     Abstract available

  4. KORSHUNOV A, Sahm F, Okonechnikov K, Ryzhova M, et al
    Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
    Acta Neuropathol. 2019 Mar 2. pii: 10.1007/s00401-019-01981.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. LESUEUR P, Lequesne J, Grellard JM, Dugue A, et al
    Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
    BMC Cancer. 2019;19:198.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  6. WILLIAMS T, Brechin D, Muncer S, Mukerji N, et al
    Meningioma and mood: exploring the potential for meningioma to affect psychological distress before and after surgical removal.
    Br J Neurosurg. 2019 Mar 4:1-5. doi: 10.1080/02688697.2019.1571163.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. LAMANO JB, Lamano JB, Li YD, DiDomenico JD, et al
    Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
    Clin Cancer Res. 2019 Mar 1. pii: 1078-0432.CCR-18-2402.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  8. MILGROM SA, Pinnix CC, Chi TL, Vu TH, et al
    Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Jan 6. pii: S0360-3016(18)30003.
    PubMed     Text format     Abstract available

  9. LE AH, Stojadinovic S, Timmerman R, Choy H, et al
    Real-Time Whole-Brain Radiation Therapy: A Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2018;100:1280-1288.
    PubMed     Text format     Abstract available


    J Neurooncol

  10. MAMPRE D, Ehresman J, Alvarado-Estrada K, Wijesekera O, et al
    Propensity for different vascular distributions and cerebral edema of intraparenchymal brain metastases from different primary cancers.
    J Neurooncol. 2019 Mar 5. pii: 10.1007/s11060-019-03142.
    PubMed     Text format     Abstract available

  11. RICHARD NM, Bernstein LJ, Mason WP, Laperriere N, et al
    Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial.
    J Neurooncol. 2019 Mar 7. pii: 10.1007/s11060-019-03130.
    PubMed     Text format     Abstract available

  12. ALBANO D, Bosio G, Bertoli M, Giubbini R, et al
    18F-FDG PET/CT in primary brain lymphoma.
    J Neurooncol. 2018;136:577-583.
    PubMed     Text format     Abstract available

  13. MORAES FY, Mendez LC, Taunk NK, Raman S, et al
    Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials.
    J Neurooncol. 2018;136:585-593.
    PubMed     Text format     Abstract available

  14. LOUIS N, Liu S, He X, Drummond DC, et al
    New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
    J Neurooncol. 2018;136:475-484.
    PubMed     Text format     Abstract available

  15. KALAMARIDES M, Essayed W, Lejeune JP, Aboukais R, et al
    Spinal ependymomas in NF2: a surgical disease?
    J Neurooncol. 2018;136:605-611.
    PubMed     Text format     Abstract available

  16. LIU F, Cox CD, Chowdhury R, Dovek L, et al
    SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.
    J Neurooncol. 2019 Mar 5. pii: 10.1007/s11060-019-03126.
    PubMed     Text format     Abstract available

  17. DONG W, Li J, Liu Q, Liu C, et al
    P21(Waf1/Cip1) and p27(Kip1) are correlated with the development and invasion of prolactinoma.
    J Neurooncol. 2018;136:485-494.
    PubMed     Text format     Abstract available

  18. VASKOVA M, Tichy M, Zamecnik J, Liby P, et al
    Cytometric analysis of cell suspension generated by cavitron ultrasonic surgical aspirator in pediatric brain tumors.
    J Neurooncol. 2019 Mar 2. pii: 10.1007/s11060-019-03135.
    PubMed     Text format     Abstract available

  19. FLEISCHHACK G, Massimino M, Warmuth-Metz M, Khuhlaeva E, et al
    Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
    J Neurooncol. 2019 Mar 4. pii: 10.1007/s11060-019-03140.
    PubMed     Text format     Abstract available

  20. MINASI S, Baldi C, Pietsch T, Donofrio V, et al
    Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    J Neurooncol. 2019 Mar 4. pii: 10.1007/s11060-019-03127.
    PubMed     Text format     Abstract available

  21. WANG K, Wang Y, Fan X, Li Y, et al
    Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
    J Neurooncol. 2018;136:523-531.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  22. TREVISAN P, Graziadio C, Rodrigues DBK, Rosa RFM, et al
    Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
    J Neuropathol Exp Neurol. 2019 Mar 6. pii: 5370415. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurosurg

  23. SHAFIQ AR, Wernicke AG, Riley CA, Morgenstern PF, et al
    Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.
    J Neurosurg. 2019 Mar 1:1-6. doi: 10.3171/2018.11.JNS181943.
    PubMed     Text format     Abstract available

  24. ROH TH, Kang SG, Moon JH, Sung KS, et al
    Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
    J Neurosurg. 2019 Mar 1:1-7. doi: 10.3171/2018.12.JNS182558.
    PubMed     Text format     Abstract available


    Neuro Oncol

  25. PRABHU RS, Turner BE, Asher AL, Marcrom SR, et al
    A Multi-Institutional Analysis of Presentation and Outcomes for Leptomeningeal Disease Recurrence After Surgical Resection and Radiosurgery for Brain Metastases.
    Neuro Oncol. 2019 Mar 4. pii: 5368947. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurology

  26. GANESH A, Galetta S
    Editors' note: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater.
    Neurology. 2019;92:494.
    PubMed     Text format    

  27. FUKUHARA N, Makifuchi T
    Reader response: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater.
    Neurology. 2019;92:494.
    PubMed     Text format    

  28. YANG X, Liu J
    Author response: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater.
    Neurology. 2019;92:495.
    PubMed     Text format    


    Neurosurgery

  29. WEDEMEYER MA, Attenello FJ
    Brainstem Gliomas: New Models Recapitulate Human Disease and Deepen Our Understanding.
    Neurosurgery. 2019 Mar 8. pii: 5372259. doi: 10.1093.
    PubMed     Text format    

  30. SEMONCHE A, Shah AH, Ivan ME, Komotar RJ, et al
    Exosomal MicroRNA in Peripheral Serum as a Noninvasive Diagnostic Biomarker for Glioblastoma.
    Neurosurgery. 2019 Mar 4. pii: 5369127. doi: 10.1093.
    PubMed     Text format    

  31. ESQUENAZI Y, Moss N, Tabar V
    In Reply: Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.
    Neurosurgery. 2019 Mar 5. pii: 5369578. doi: 10.1093.
    PubMed     Text format    


    PLoS One

  32. RAKOTONJANAHARY J, Gravier N, Lambron J, De Carli E, et al
    Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    PLoS One. 2019;14:e0212107.
    PubMed     Text format     Abstract available

  33. ZIMMERMANN M, Rossler K, Kaltenhauser M, Grummich P, et al
    Comparative fMRI and MEG localization of cortical sensorimotor function: Bimodal mapping supports motor area reorganization in glioma patients.
    PLoS One. 2019;14:e0213371.
    PubMed     Text format     Abstract available

  34. TANAKA Y, Nakazawa T, Nakamura M, Nishimura F, et al
    Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.
    PLoS One. 2019;14:e0212455.
    PubMed     Text format     Abstract available

  35. DENNISON KL, Chack AC, Hickman MP, Harenda QE, et al
    Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases.
    PLoS One. 2018;13:e0204727.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: